1-3 of 3
Changying Jiang
Close
Sort by
Journal Articles

Dual targeting of CDK4/6 and Bcl-2 exhibits a potent antitumor effect on mantle cell lymphoma

Yuxuan Che, Yang Liu, Yijing Li, Joseph M. McIntosh, Alexa Jordan, Fangfang Yan, Wei Wang, Lei Nie, Heng-Huan Lee, Jingling Jin, Yixin Yao, Zhongming Zhao, Vivian Changying Jiang, Michael Wang
Journal: Blood Advances
Blood Adv (2023) 7 (14): 3361–3365.
https://doi.org/10.1182/bloodadvances.2022008954
Published: 2023
Includes: Supplemental data
Journal Articles

Inhibition of B-cell receptor signaling disrupts cell adhesion in mantle cell lymphoma via RAC2

Wenjun Wu, Weige Wang, Carrie A. Franzen, Hui Guo, Jimmy Lee, Yan Li, Madina Sukhanova, Dong Sheng, Girish Venkataraman, Mei Ming, Pin Lu, Anhui Gao, Chunmei Xia, Jia Li, Liang Leo Zhang, Vivian Changying Jiang, Michael L. Wang, Jorge Andrade, Xiaoyan Zhou, Y. Lynn Wang
Journal: Blood Advances
Blood Adv (2021) 5 (1): 185–197.
https://doi.org/10.1182/bloodadvances.2020001665
Published: 2021
Includes: Supplemental data
Journal Articles

Genomic profiles and clinical outcomes of de novo blastoid/pleomorphic MCL are distinct from those of transformed MCL

Clinical Trials & Observations
Preetesh Jain, Shaojun Zhang, Rashmi Kanagal-Shamanna, Chi Young Ok, Krystle Nomie, Graciela Nogueras Gonzalez, Omarya Gonzalez-Pagan, Holly A. Hill, Hun Ju Lee, Luis Fayad, Jason Westin, Loretta Nastoupil, Frederick Hagemeister, Wendy Chen, Onyeka Oriabure, Maria Badillo, Changying Jiang, Yao Yixin, Shaoying Li, Guilin Tang, C. Cameron Yin, Keyur P. Patel, Leonard Jeffrey Medeiros, Ranjit Nair, Sairah Ahmed, Swaminathan P. Iyer, Selvi Thirumurthi, Richard Champlin, Guofan Xu, Pan Tinsu, David Santos, Ruiping Wang, Guangchun Han, Jianhua Zhang, Xingzhi Song, Sattva Neelapu, Jorge Romaguera, Andy Futreal, Christopher Flowers, Nathan Fowler, Linghua Wang, Michael L. Wang
Journal: Blood Advances
Blood Adv (2020) 4 (6): 1038–1050.
https://doi.org/10.1182/bloodadvances.2019001396
Published: 2020
Includes: Supplemental data